Literature DB >> 10832953

Delayed death from pulmonary tuberculosis: unsuspected subtherapeutic drug levels.

R S Morehead1.   

Abstract

A patient with fulminant pulmonary tuberculosis died after 41 days of intensive care despite pansensitive organisms and no known underlying immunosuppression. Two factors leading to death in this patient were a delay in seeking medical attention and a subtherapeutic serum level of rifampin, though no obvious evidence of malabsorption existed. Malabsorption of antitubercular drugs is under-recognized and of extreme importance in the treatment of critically ill patients with active pulmonary tuberculosis. Factors associated with mortality from tuberculosis and selected aspects of critical care management are discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10832953

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  5 in total

Review 1.  Large Porous Hollow Particles: Lightweight Champions of Pulmonary Drug Delivery.

Authors:  Sachin Gharse; Jennifer Fiegel
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

2.  Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children.

Authors:  Aparna Mukherjee; Thirumurthy Velpandian; Mohit Singla; Kunwar Kanhiya; Sushil K Kabra; Rakesh Lodha
Journal:  BMC Infect Dis       Date:  2015-03-14       Impact factor: 3.090

3.  Elucidating drug-enzyme interactions and their structural basis for improving the affinity and potency of isoniazid and its derivatives based on computer modeling approaches.

Authors:  Auradee Punkvang; Patchreenart Saparpakorn; Supa Hannongbua; Peter Wolschann; Pornpan Pungpo
Journal:  Molecules       Date:  2010-04-16       Impact factor: 4.411

4.  Molecular fingerprinting reveals familial transmission of rifampin-resistant tuberculosis in Kuwait.

Authors:  Eiman Mokaddas; Suhail Ahmad; Adnan T Abal; Abdul S Al-Shami
Journal:  Ann Saudi Med       Date:  2005 Mar-Apr       Impact factor: 1.526

5.  Determinants of serum concentration of first-line anti-tuberculosis drugs from China.

Authors:  Qian Lei; Hao Wang; Yuan Zhao; Liyun Dang; Changsheng Zhu; Xiaohui Lv; Hui Wang; Jun Zhou
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.